Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 35, 2013 - Issue 3: Traumatic Brain Injury
145
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Overexpression of the nuclear factor kappaB inhibitor A20 is neurotoxic after an excitotoxic injury to the immature rat brain

, , , , , & show all
Pages 308-319 | Published online: 12 Nov 2013

References

  • Mattson MP. NF-kappaB in the survival and plasticity of neurons. Neurochem Res. 2005;30(6–7):883–93.
  • Kaltschmidt B, Widera D, Kaltschmidt C. Signaling via NF-kappaB in the nervous system. Biochim Biophys Acta. 2005;1745(3):287–99.
  • Acarin L, Gonzalez B, Castellano B. Triflusal posttreatment inhibits glial nuclear factor-kappaB, downregulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain. Stroke. 2001;32(10):2394–402.
  • Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, et al.. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000;289(5488):2350–4.
  • Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, et al.. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004;5(10):1052–60.
  • Silverman N, Fitzgerald K. DUBbing down innate immunity. Nat Immunol. 2004;5(10):1010–2.
  • Wertz IE, O’Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, et al.. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430(7000):694–9.
  • Heyninck K, Beyaert R. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem Sci. 2005;30(1):1–4.
  • Vereecke L, Beyaert R, van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009;30(8):383–91.
  • Staub O, Rotin D. Role of ubiquitylation in cellular membrane transport. Physiol Rev. 2006;86(2):669–707.
  • Grey ST, Arvelo MB, Hasenkamp W, Bach FH, Ferran C. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med. 1999;190(8):1135–46.
  • Liuwantara D, Elliot M, Smith M, Yam AO, Walters SN, Marino E, et al.. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection. Diabetes. 2006;55(9):2491–501.
  • Daniel S, Arvelo MB, Patel VI, Longo CR, Shrikhande G, Shukri T, et al.. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood. 2004;104(8):2376–84.
  • Storz P, Doppler H, Ferran C, Grey ST, Toker A. Functional dichotomy of A20 in apoptotic and necrotic cell death. Biochem J. 2005;387(Pt 1):47–55.
  • Patel VI, Daniel S, Longo CR, Shrikhande GV, Scali ST, Czismadia E, et al.. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia. FASEB J. 2006;20(9):1418–30.
  • Malewicz M, Zeller N, Yilmaz ZB, Weih F. NF kappa B controls the balance between Fas and tumor necrosis factor cell death pathways during T cell receptor-induced apoptosis via the expression of its target gene A20. J Biol Chem. 2003;278(35):32825–33.
  • Quintana A, Giralt M, Rojas S, Penkowa M, Campbell IL, Hidalgo J, et al.. Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury. J Neurosci Res. 2005;82(5):701–16.
  • Ferriero DM. Neonatal brain injury. N Engl J Med. 2004;351(19):1985–95.
  • Vannucci SJ, Hagberg H. Hypoxia–ischemia in the immature brain. J Exp Biol. 2004;207(Pt 18):3149–54.
  • Romijn HJ, Hofman MA, Gramsbergen A. At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby? Early Hum Dev. 1991;26(1):61–7.
  • Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev. 1979;3(1):79–83.
  • McDonald JW, Silverstein FS, Johnston MJ. Neurotoxicity of N-methyl-d-aspartate is markedly enhanced in developing rat central nervous system’, Brain Res. 1988;459(1):200–3.
  • Aris A, Feliu JX, Knight A, Coutelle C, Villaverde A. Exploiting viral cell-targeting abilities in a single polypeptide, non-infectious, recombinant vehicle for integrin-mediated DNA delivery and gene expression. Biotechnol Bioeng. 2000;68(6):689–96.
  • Aris A, Villaverde A. Engineering nuclear localization signals in modular protein vehicles for gene therapy. Biochem Biophys Res Commun. 2003;304(4):625–31.
  • Peluffo H, Aris A, Acarin L, Gonzalez P, Villaverde A, Castellano B, et al.. Nonviral gene delivery to the central nervous system based on a novel integrin-targeting multifunctional protein. Hum Gene Ther. 2003;14(13):1215–23.
  • Peluffo H, Acarin L, Aris A, Gonzalez P, Villaverde A, Castellano B, et al.. Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector. BMC Neurosci. 2006;7:35.
  • Peluffo H, Gonzalez P, Aris A, Saura J, Villaverde A, Castellano B, et al.. RGD domains neuroprotect the immature brain by a glial-dependent mechanism. Ann Neurol. 2007;62(3):251–61.
  • Klinkenberg M, van Huffel S, Heyninck K, Beyaert R. Functional redundancy of the zinc fingers of A20 for inhibition of NF-kappaB activation and protein–protein interactions. FEBS Lett. 2001;498(1):93–7.
  • Acarin L, Gonzalez B, Castro AJ, Castellano B. Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: microglial/macrophage response and major histocompatibility complex class I and II expression. Neuroscience. 1999;89(2):549–65.
  • Acarin L, Gonzalez B, Castellano B, Castro AJ. Quantitative analysis of microglial reaction to a cortical excitotoxic lesion in the early postnatal brain. Exp Neurol. 1997;147(2):410–7.
  • Ikonomidou C, Mosinger JL, Salles KS, Labruyere J, Olney JW. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J Neurosci. 1989;9(8):2809–18.
  • Acarin L, González B, Hidalgo J, Castro AJ, Castellano B. Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: astroglial response and metallothionein expression. Neuroscience. 1999;92(3):827–39.
  • Krikos A, Laherty CD, Dixit VM. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem. 1992;267(25):17971–6.
  • Bakalkin G, Yakovleva T, Terenius L. NF-kappa B-like factors in the murine brain. Developmentally-regulated and tissue-specific expression. Brain Res Mol Brain Res. 1993;20(1–2):137–46.
  • Rattner A, Korner M, Walker MD, Citri Y. NF-kappa B activates the HIV promoter in neurons. EMBO J. 1993;12(11):4261–7.
  • Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA. Constitutive NF-kappa B activity in neurons. Mol Cell Biol. 1994;14(6):3981–92.
  • Bhakar AL, Tannis LL, Zeindler C, Russo MP, Jobin C, Park DS, et al.. Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci. 2002;22(19):8466–75.
  • Peluffo H, Acarin L, Faiz M, Castellano B, Gonzalez B. Cu/Zn superoxide dismutase expression in the postnatal rat brain following an excitotoxic injury. J Neuroinflammation. 2005;2(1):12.
  • Acarin L, Gonzalez B, Castellano B. STAT3 and NFkappaB activation precedes glial reactivity in the excitotoxically injured young cortex but not in the corresponding distal thalamic nuclei. J Neuropathol Exp Neurol. 2000;59(2):151–63.
  • Acarin L, Peluffo H, Gonzalez B, Castellano B. Expression of inducible nitric oxide synthase and cyclooxygenase-2 after excitotoxic damage to the immature rat brain. J Neurosci Res. 2002;68(6):745–54.
  • Sanchez-Burgos G, Hernandez-Pando R, Campbell IL, Ramos-Castaneda J, Ramos C. Cytokine production in brain of mice experimentally infected with dengue virus. Neuroreport. 2004;15(1):37–42.
  • Yu L, Miao H, Hou Y, Zhang B, Guo L. Neuroprotective effect of A20 on TNF-induced postischemic apoptosis. Neurochem Res. 2006;31(1):21–32.
  • Villapol S, Acarin L, Faiz M, Rohn TT, Castellano B, Gonzalez B. Distinct spatial and temporal activation of caspase pathways in neurons and glial cells after excitotoxic damage to the immature rat brain. J Neurosci Res. 2007;85(16):3545–56.
  • Fridmacher V, Kaltschmidt B, Goudeau B, Ndiaye D, Rossi FM, Pfeiffer J, et al.. Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. J Neurosci. 2003;23(28):9403–8.
  • Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell. 1995;80(2):321–30.
  • Kassed CA, Willing AE, Garbuzova-Davis S, Sanberg PR, Pennypacker KR. Lack of NF-kappaB p50 exacerbates degeneration of hippocampal neurons after chemical exposure and impairs learning. Exp Neurol. 2002;176(2):277–88.
  • Fernyhough P, Smith DR, Schapansky J, van der Ploeg R, Gardiner NJ, Tweed CW, et al.. Activation of nuclear factor-kappaB via endogenous tumor necrosis factor alpha regulates survival of axotomized adult sensory neurons. J Neurosci. 2005;25(7):1682–90.
  • Koulich E, Nguyen T, Johnson K, Giardina C, D’Mello S. NF-kappaB is involved in the survival of cerebellar granule neurons: association of IkappaBbeta [correction of Ikappabeta] phosphorylation with cell survival. J Neurochem. 2001;76(4):1188–98.
  • Yu Z, Zhou D, Bruce-Keller AJ, Kindy MS, Mattson MP. Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J Neurosci. 1999;19(20):8856–65.
  • Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A. A dual role of the NF-kappaB pathway in neonatal hypoxic–ischemic brain damage. Stroke. 2008; 39(9):2578–86.
  • Kaltschmidt B, Uherek M, Wellmann H, Volk B, Kaltschmidt C. Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc Natl Acad Sci USA. 1999;96(16):9409–14.
  • Lang H, Schulte BA, Zhou D, Smythe N, Spicer SS, Schmiedt RA. Nuclear factor kappaB deficiency is associated with auditory nerve degeneration and increased noise-induced hearing loss. J Neurosci. 2006;26(13):3541–50.
  • Duckworth EA, Butler T, Collier L, Pennypacker KR. NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res. 2006;1088(1):167–75.
  • Yu Z, Zhou D, Cheng G, Mattson MP. Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington’s disease. J Mol Neurosci. 2000;15(1):31–44.
  • Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med. 1999;5(5):554–9.
  • Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, KarjalainenLindsberg ML, et al.. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke. 2004;35(4):987–991.
  • Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J, et al.. IKK mediates ischemia-induced neuronal death. Nat Med. 2005;11(12):1322–9.
  • Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, et al.. Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab. 2005;25(1):30–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.